ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,407, issued on May 27, was assigned to ST PHI THERAPEUTICS Co. LTD. (Hangzhou, China).

"Universal T cells and the method of use thereof" was invented by Lingfeng Liu (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "A series of recombinant DNA constructs and a method is disclosed for use in immunological therapy in general; and in disrupting T cell receptor (TCR), human leukocyte antigens (HLA) class I and NKG2D (Natural-Killer Group 2, member D) ligand expression in particular, with the effect of producing highly compatible autologous universal T cells for further genetically engineering for allogeneic administration. A Universal T (UT) const...